feasibility study of computer vision for quantifying cardiac amyloid burden in biopsies
Published 1 month ago • 17 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
2:19
feasibility of biomarker-driven strategy in high-risk lbcl: final results from nordic phase ii study
-
0:52
how novel technologies and machine learning are impacting drug research in amyloidosis
-
0:45
difference between quality of life & patient-reported outcomes
-
7:25
ai in hematology: advances, challenges, and future applications
-
3:37
biomarker analysis of luspatercept versus epoetin alfa in lr-mds in the phase iii commands study
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
13:57
computer vision in healthcare and medicine
-
18:51
healthcare reform and hematology – the value of a laboratory and pathology utilization program
-
1:34
the future role of ai models in hematology and the need for high-quality data sets
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
6:07
a crispr approach to hematological research
-
4:48
an insight into the management of cytopenias in mf
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
0:52
insights from advance iv study: efgartigimod increases platelet counts of patients with itp
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
1:58
hematologists of the future: new training curriculum and medical education